Alexander J. THOMPSON
St Vincent's Hospital Melbourne and the University of Melbourne
Position/ Affiliation：
Alex Thompson is Professor-Director of the Department of Gastroenterology at St Vincent’s Hospital and the University of Melbourne, Australia, NHMRC Practitioner Fellow and Adjunct Assistant Professor of the Department of Gastroenterology, Duke University Medical Center. Professor Thompson is the Program Director for the Victorian Statewide Hepatitis Service, Australia, contracted to the Victorian Government’s Department of Justice and Regulation.
Professional Organization (Academic Society Activities)：
He is a former Executive Council member of the Asian Pasific Association of the Study of the Liver (APASL). He is a Board Member of the Gastroenterological Society of Australia (GESA). He is a Fellow the American Association for the Study of the Liver (AASLD), and a member of the European Association for the Study of the Liver (EASL).
Scientific Activity (Lecture or Editor)：
Associate Editor for the journal "Hepatology".
Specialty/ Research Field：
His research focusses on improving outcomes for people living with viral hepatitis. He was involved in the discovery of IL28B polymorphism as a predictor of treatment outcome in HCV, and is an active clinical investigator for trials evaluating the efficacy of novel antiviral DAA regimens. With the development of DAA therapy for HCV, he has more recently been actively pursuing the development and evaluation of new models of care for people with HCV, with a focus on prisoners and treatment as prevention to eliminate transmission and reduce prevalence of HCV in Australia.
Other Activities：
He has published widely in journals including Nature, New England Journal of Medicine, Journal of the American Medical Association, Gastroenterology, Hepatology, Gut and Journal of Hepatology.
Alex Thompson is Professor-Director of the Department of Gastroenterology at St Vincent’s Hospital and the University of Melbourne, Australia, NHMRC Practitioner Fellow and Adjunct Assistant Professor of the Department of Gastroenterology, Duke University Medical Center. Professor Thompson is the Program Director for the Victorian Statewide Hepatitis Service, Australia, contracted to the Victorian Government’s Department of Justice and Regulation.
Professional Organization (Academic Society Activities)：
He is a former Executive Council member of the Asian Pasific Association of the Study of the Liver (APASL). He is a Board Member of the Gastroenterological Society of Australia (GESA). He is a Fellow the American Association for the Study of the Liver (AASLD), and a member of the European Association for the Study of the Liver (EASL).
Scientific Activity (Lecture or Editor)：
Associate Editor for the journal "Hepatology".
Specialty/ Research Field：
His research focusses on improving outcomes for people living with viral hepatitis. He was involved in the discovery of IL28B polymorphism as a predictor of treatment outcome in HCV, and is an active clinical investigator for trials evaluating the efficacy of novel antiviral DAA regimens. With the development of DAA therapy for HCV, he has more recently been actively pursuing the development and evaluation of new models of care for people with HCV, with a focus on prisoners and treatment as prevention to eliminate transmission and reduce prevalence of HCV in Australia.
Other Activities：
He has published widely in journals including Nature, New England Journal of Medicine, Journal of the American Medical Association, Gastroenterology, Hepatology, Gut and Journal of Hepatology.
The lecture video：0
Abstract：0
40
0
0
The academic assignments are as follows
| Date (UTC+8) | Time (UTC+8) | Local Time | Room | Session | Role | Talk Title |
|---|---|---|---|---|---|---|
| 2022-09-18 | 13:45-15:15 | 2022-09-18,13:45-15:15 | Meeting Room 2 |
Concurrent Session 14 - Basic Research in Liver Disease |
Moderator |